000102091 001__ 102091
000102091 005__ 20220426091135.0
000102091 0247_ $$2doi$$a10.1007/s10529-020-02919-9
000102091 0248_ $$2sideral$$a118213
000102091 037__ $$aART-2020-118213
000102091 041__ $$aeng
000102091 100__ $$aMora-Sánchez, Brenda
000102091 245__ $$aEffect of a novel postbiotic containing lactic acid bacteria on the intestinal microbiota and disease resistance of rainbow trout (Oncorhynchus mykiss)
000102091 260__ $$c2020
000102091 5060_ $$aAccess copy available to the general public$$fUnrestricted
000102091 5203_ $$aObjective: This study was aimed to assess the effect of a novel postbiotic on bacterial community composition and structure within the intestinal ecosystem of rainbow trout (Oncorhynchus mykiss), as well as evaluate its capacity to protect rainbow trout from Lactococcus garvieae infection.
Results: After 30 days of dietary postbiotic supplementation, high-throughput 16S rRNA gene sequencing revealed that bacterial community composition, diversity and richness were significantly higher in treated fish than in control fish. The proportion of sequences affiliated to the phylum Tenericutes, and to a lesser extent, the phyla Spirochaetes and Bacteroidetes was increased in fish fed a postbiotic-enriched diet compared to control fish, whereas the abundance of Fusobacteria was higher in control fish. Moreover, the treated fish showed significantly (p < 0.05) improved protection against L. garvieae compared to control fish.
Conclusions: These findings suggest that dietary postbiotic supplementation may represent an environmentally friendly strategy for preventing and controlling diseases in aquaculture.
000102091 536__ $$9info:eu-repo/grantAgreement/ES/MINECO/AGL2014-54683-R$$9info:eu-repo/grantAgreement/ES/UZ/UZ-SANTANDER
000102091 540__ $$9info:eu-repo/semantics/openAccess$$aAll rights reserved$$uhttp://www.europeana.eu/rights/rr-f/
000102091 590__ $$a2.461$$b2020
000102091 591__ $$aBIOTECHNOLOGY & APPLIED MICROBIOLOGY$$b107 / 159 = 0.673$$c2020$$dQ3$$eT3
000102091 592__ $$a0.548$$b2020
000102091 593__ $$aApplied Microbiology and Biotechnology$$c2020$$dQ2
000102091 593__ $$aMedicine (miscellaneous)$$c2020$$dQ2
000102091 593__ $$aBiotechnology$$c2020$$dQ2
000102091 593__ $$aBioengineering$$c2020$$dQ2
000102091 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/acceptedVersion
000102091 700__ $$0(orcid)0000-0002-6866-9347$$aBalcázar, José Luis
000102091 700__ $$0(orcid)0000-0001-5095-3289$$aPérez-Sánchez, Tania$$uUniversidad de Zaragoza
000102091 7102_ $$11009$$2773$$aUniversidad de Zaragoza$$bDpto. Patología Animal$$cÁrea Sanidad Animal
000102091 773__ $$g2020, 42 (2020), 1957–1962$$pBiotechnol. lett.$$tBiotechnology Letters$$x0141-5492
000102091 8564_ $$s90557$$uhttps://zaguan.unizar.es/record/102091/files/texto_completo.pdf$$yPostprint
000102091 8564_ $$s822641$$uhttps://zaguan.unizar.es/record/102091/files/texto_completo.jpg?subformat=icon$$xicon$$yPostprint
000102091 909CO $$ooai:zaguan.unizar.es:102091$$particulos$$pdriver
000102091 951__ $$a2022-04-26-08:53:14
000102091 980__ $$aARTICLE